Showing results (1971-1980 of 2,503) with videos related to

Sort By:
Pageof 251
The American Journal of Cardiology|April 4, 1998
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial IschemiaS Borzak, C P Cannon, P L Kraft, et al.
The American Journal of Psychiatry|May 3, 2023
Racial and Ethnic Bias in the Diagnosis of Alcohol Use Disorder in VeteransRachel Vickers-Smith, Amy C Justice, William C Becker, et al.
Cardiology in the Young|January 9, 2025
Mechanisms of exercise-related neurocardiogenic syncope and the relationship between resting and dynamic cardiac testingBradley J Conant, Kristian C Becker, Garick D Hill, et al.
Implementation Science : IS|November 30, 2018
Testing implementation facilitation of a primary care-based collaborative care clinical program using a hybrid type III interrupted time series design: a study protocolAmanda M Midboe, Steve Martino, Sarah L Krein, et al.
Oncoimmunology|May 8, 2015
Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancerMads Duus Hjortsø, Stine Kiaer Larsen, Per Kongsted, et al.
Journal of Neuroscience Methods|April 17, 2019
Studies on long term behavioural changes in group-housed rat models of brain and spinal cord injury using an automated home cage recording systemPing K Yip, George E Chapman, Rowland R Sillito, et al.
AIDS and Behavior|September 20, 2015
Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIVWilliam C Becker, Kirsha Gordon, E Jennifer Edelman, et al.
Pain Management|December 7, 2017
Subcutaneous local anesthetic infusion could eliminate use of epidural analgesia after the Nuss procedureSandra K Kabagambe, Laura F Goodman, Y Julia Chen, et al.
Circulation|May 2, 2007
Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1Nauder Faraday, Lisa R Yanek, Rasika Mathias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2013
Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-upSelma Ugurel, Thomas Mentzel, Jochen Utikal, et al.
Pageof 251